Results 251 to 260 of about 59,868 (281)
Some of the next articles are maybe not open access.
Nifedipine and Erythromelalgia
Annals of Internal Medicine, 1983Excerpt To the editor: Erythromelalgia, a skin eruption with intense red discoloration, elevated skin temperature, and burning pain, usually involves the hands, feet, or lower legs.
Marvin B. Padnick +2 more
openaire +4 more sources
Nifedipine in the treatment of hypertension
European Journal of Clinical Pharmacology, 1983Nifedipine, a calcium antagonist with a predominant vasodilator action, was evaluated for the treatment of hypertension. A 20 mg-tablet, with a slower absorption and a more sustained blood-level than provided by the 10 mg-capsule was administered to 20 patients. The duration of the trial was 20 weeks.
S. Blake +3 more
openaire +3 more sources
Pharmacokinetics of nifedipine in Taiwanese
Biopharmaceutics & Drug Disposition, 2004AbstractTo elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat® capsule as a reference drug after overnight fasting.
Yow Shieng Uang +3 more
openaire +3 more sources
Pharmacokinetics of nifedipine.
International journal of clinical pharmacology research, 1985The pharmacokinetics of a slow-release formulation of nifedipine were studied following oral administration of a single 20 mg tablet in nine young male volunteers. Blood samples were collected and nifedipine concentrations analysed by gas liquid chromatography.
PASANISI, FABRIZIO +2 more
openaire +2 more sources
Nifedipine in Antihypertensive Therapy
Archives of Internal Medicine, 1985To the Editor. —We read with interest the article by Evans et al 1 in the May 1984Archives. Their results are similar to ours in demonstrating nifedipine efficacy as a substitute for hydralazine and captopril in combination antihypertensive therapy. 2 Recently, McAreavey et al 3 suggested hydralazine as the best third-line drug.
Ehud Grossman +2 more
openaire +3 more sources
Pharmacology of Nifedipine [PDF]
, 1975 This paper is a brief synopsis of the main pharmacological properties of nifedipine in connection with a concept of its hemodynamic action.
openaire +1 more source
Nifedipine-Induced Hypokalemia
Drug Intelligence & Clinical Pharmacy, 1986Nifedipine, a calcium-channel blocking agent, has been reported to cause many side effects, particularly in the cardiovascular system. A case of nifedipine-induced hypokalemia is presented, with a discussion on the presumable mechanism involved in this phenomenon.
Shoshana Armon, Moshe Tishler
openaire +3 more sources
Nifedipine and Agranulocytosis
Annals of Internal Medicine, 1983Excerpt To the editor: We write to report a case of agranulocytosis we believe was probably caused by nifedipine.
Richard H. Turner, Arnold J. Voth
openaire +2 more sources
Nifedipine for Hypertensive Emergencies
JAMA: The Journal of the American Medical Association, 1997To the Editor. —We read with interest the report of Dr Grossman and colleagues 1 and the accompanying Editorial by Dr Winker 2 on sublingual nifedipine capsules. We recently performed a systematic search of the available literature on the use of short-acting nifedipine preparations in hypertensive emergencies and reached different conclusions.
SEMPLICINI, ANDREA +1 more
openaire +3 more sources
Nifedipine in Intestinal Colic
JAMA: The Journal of the American Medical Association, 1990To the Editor.— Nifedipine, a calcium channel blocking agent, relaxes smooth muscle and has been widely used for the treatment of coronary insufficiency and hypertension. Used for its spasmolytic effect, nifedipine has been found to be effective in relieving acute and recurrent urinary colic. 1 It exhibits relaxant activity in the intestinal tract and
openaire +3 more sources